Medical Technology

@xconomy.com 3 years ago

Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More

@xconomy.com 4 years ago

Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More

@xconomy.com 4 years ago

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

@xconomy.com 4 years ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@xconomy.com 4 years ago

Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone

@xconomy.com 4 years ago

Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More

@xconomy.com 4 years ago

Review: Inside the House of Lies at Theranos

@xconomy.com 5 years ago

Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise

@xconomy.com 5 years ago

Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More

@xconomy.com 5 years ago

Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More

@xconomy.com 5 years ago

Magnolia Medical Captures $20M to Reduce Blood Culture Contamination

@xconomy.com 5 years ago

Sentinel Healthcare Raises $2M For Hypertension-Monitoring Software

@xconomy.com 5 years ago

Providence Ventures Raises $150M to Invest in Healthtech Startups

@xconomy.com 5 years ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@xconomy.com 5 years ago

Six Life Science Firms Close Q3 with an IPO, More Are on the Way